Does MIRVASO Cause Condition aggravated? 190 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Condition aggravated have been filed in association with MIRVASO. This represents 45.7% of all adverse event reports for MIRVASO.
190
Reports of Condition aggravated with MIRVASO
45.7%
of all MIRVASO reports
1
Deaths
1
Hospitalizations
How Dangerous Is Condition aggravated From MIRVASO?
Of the 190 reports, 1 (0.5%) resulted in death, 1 (0.5%) required hospitalization.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRVASO. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does MIRVASO Cause?
Erythema (260)
Flushing (161)
Skin burning sensation (114)
Feeling hot (93)
Rebound effect (89)
Off label use (81)
Rash macular (47)
Pain of skin (43)
Drug ineffective (38)
Inappropriate schedule of drug administration (31)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which MIRVASO Alternatives Have Lower Condition aggravated Risk?
MIRVASO vs MISOPROSTOL
MIRVASO vs MOMETASONE
MIRVASO vs MOMETASONE FUROATE
MIRVASO vs MONTELUKAST
MIRVASO vs MORPHINE